She leads early career development programs and strategic operations for their discovery organization to ensure that their business is running efficiently
I practice evidence-based medicine by integrating pharmacology, exposure, epidemiology, and clinical data to drive drug development decisions with a patient-centric focus.
Dr. Nancy Guillen was recently appointed as an Associate Director in Upstream Development at (J&J) Innovative Medicines
David Swain works in works in the Advanced Technology Business unit at Edwards Lifesciences
Dr. Alia Toro is a Medical Sciences Liaison (MSL) who provides support to the Oncology Department at Merck, Puerto Rico.
Dr. Ivelisse Cruz-Torres works in matrix teams with the goal of evaluating potential targets to treat neurodegenerative diseases.
Dr. Hugo Caicedo is a Sr. Director in the Accelerated R&D Leadership Program at Eli Lilly and Company.
I work on establishing robust formulations and manufacturing processes to support late-stage development of synthetic drug programs.
I support nonclinical safety studies for IND filing and clinical trials
I support the growth of the research division by maintaining effective pricing strategies such as contracts and negotiations to ensure a high level of customer satisfaction.
I manage laboratory teams and monitor the quality of their work, making sure reagents for projects are dispatched in a timely manner.
I lead and develop a team of field-based oncology Medical Science Liaisons where I provide guidance on medical insight
I utilize x-rays, MRIs, and 3D modeling programs while collaborating with surgeons to provide them with the desired results for their patients’ surgeries.
I lead research studies that use real-world data to support precision medicine strategy for the oncology products of the company.
I help with the research and development of next generation enabling technology and features for implantable neurostimulators.
As the 2022 Research and Development trainee for Merck’s KGaA, Darmstadt, Germany Rotational Program, I work with the In-Vitro Research and Development team to improve biosafety testing assays.